Glufosfamide as a new oxazaphosphorine anticancer agent.
Lidia Mazur1, Małgorzata Opydo-Chanek, Marta Stojak
1Department of Experimental Hematology, Jagiellonian University, Krakow, Poland. lidia.mazur@uj.edu.pl
Anti-Cancer Drugs
|March 24, 2011
Summary
Glufosfamide, a novel glucose conjugate of ifosfamide, shows promise as a new anticancer agent. Its therapeutic potential and mechanism of action are under investigation in preclinical and clinical studies.
Area of Science:
- Oncology
- Medicinal Chemistry
Background:
- Glufosfamide is a novel oxazaphosphorine derivative, specifically a glucose conjugate of ifosfamide.
- It links the active alkylating metabolite, isophosphoramide mustard, to a β-D-glucose molecule.
Purpose of the Study:
- To review and assess the current knowledge on glufosfamide's anticancer potential.
- To consolidate findings from preclinical studies and clinical trials.
Main Methods:
- Systematic literature review of preclinical studies and clinical trials.
- Searched SCOPUS and MEDLINE databases for relevant papers and abstracts.
Main Results:
- Glufosfamide is an attractive candidate for cancer therapy.
- Its mode of action on normal and pathological cells requires further investigation.
Conclusions:
- Further assessment of glufosfamide's anticancer potential is crucial for therapeutic development.
- Ongoing experimental and clinical investigations are defining its role in cancer treatment.
![An Automated Radiosynthesis of [68Ga]Ga-FAPI-46 for Routine Clinical Use](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F66708.jpg&w=3840&q=50)
![Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F68356.jpg&w=3840&q=50)
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...